Differential expression of glucocorticoid receptor in human breast tissues and related neoplasms

Journal of Pathology

Volumn 209, Issue 3, 2006, Pages 317-327

  Lien, H C ^a   Lu, Y S ^a   Cheng, A L ^a   Chang, W C ^a   Jeng, Y M ^a   Kuo, Y H ^a   Huang, C S ^a   Chang, K J ^a   Yao, Yu Tung ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Glucocorticoid receptor; Luminal epithelial cells; Metaplastic carcinoma of the breast; Myoepithelial cells

Indexed keywords

ESTROGEN RECEPTOR ALPHA; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ARTICLE; BENIGN TUMOR; BREAST CARCINOGENESIS; BREAST CARCINOMA; BREAST TUMOR; CANCER CELL; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; CYSTOSARCOMA PHYLLOIDES; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; METHYLATION; MYOEPITHELIUM; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; SAMPLE;

BASE SEQUENCE; BREAST; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DNA METHYLATION; DNA, NEOPLASM; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION; HUMANS; IMMUNOENZYME TECHNIQUES; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; PHYLLODES TUMOR; PROMOTER REGIONS (GENETICS); RECEPTORS, GLUCOCORTICOID;

EID: 33745712783     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.1982     Document Type: Article

References (37)

1. Wang JC, Derynck MK, Nonaka DF, Khodabakhsh DB, Haqq C, Yamamoto KR. Chromatin immunoprecipitation (ChIP) scanning identifies primary glucocorticoid receptor target genes. Proc Natl Acad Sci U S A 2004;101:15603-15608.
2. Wintermantel TM, Bock D, Fleig V, Greiner EF, Schutz G. The epithelial glucocorticoid receptor is required for the normal timing of cell proliferation during mammary lobuloalveolar development but is dispensable for milk production. Mol Endocrinol 2005;19:340-349.
3. Beato M, Herrlich P, Schutz G. Steroid hormone receptors. Many actors in search of a plot. Cell 1995;83:851-957.
4. Imagawa W, Bandyopadhyay GK, Nandi S. Regulation of mammary epithelial cell growth in mice and rats. Endocr Rev 1990;11:494-523.
5. Korach KS, Couse JF, Curtis SW, Washburn TF, Lindzey J, Kimbro KS, et al. Estrogen receptor gene disruption: molecular characterization and experimental and clinical phenotypes. Recent Prog Horm Res 1996;51:159-186; discussion 186-158.
6. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA Jr, et al. Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995;9:2266-2278.
7. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, et al. Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 1999;210:96-106.
8. Reichardt HM, Horsch K, Grone HJ, Kolbus A, Beug H, Hynes N, et al. Mammary gland development and lactation are controlled by different glucocorticoid receptor activities. Ear J Endocrinol 2001;145:519-527.
9. Schmidt S, Rainer J, Ploner C, Presul E, Riml S, Kofler R. Glucocorticoid-induced apoptosis and glucocorticoid resistance: molecular mechanisms and clinical relevance. Cell Death Differ 2004;11(Suppl 1):S45-S55.
10. Tangir J, Bonafe N, Gilmore-Hebert M, Henegariu O, Chambers SK. SGK1, a potential regulator of c-fms related breast cancer aggressiveness. Clin Exp Metastasis 2004;21:477-483.
11. Wu W, Pew T, Zou M, Pang D, Conzen SD. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. J Biol Chem 2005;280:4117-4124.
12. Lippman M, Bolan G, Huff K. The effects of glucocorticoids and progesterone on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 1976;36:4602-4609.
13. Leo JC, Guo C, Woon CT, Aw SE, Lin VC. Glucocorticoid and mineralocorticoid cross-talk with progesterone receptor to induce focal adhesion and growth inhibition in breast cancer cells. Endocrinology 2004;145:1314-1321.
14. Palmieri D, Halverson DO, Ouatas T, Horak CE, Salerno M, Johnson J, et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. J Natl Cancer Inst 2005;97:632-642.
15. Horwitz KB, Zava DT, Thilagar AK, Jensen EM, McGuire WL. Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res 1978;38:2434-2437.
16. Hall RE, Lee CS, Alexander IE, Shine J, Clarke CL, Sutherland RL. Steroid hormone receptor gene expression in human breast cancer cells: inverse relationship between oestrogen and glucocorticoid receptor messenger RNA levels. Int J Cancer 1990;46:1081-1087.
17. Fazekas AG, MacFarlane JK. Macromolecular binding of glucocorticoids in human mammary carcinoma. Cancer Res 1977;37:640-645.
18. Ioannidis C, Papamichail M, Agnanti N, Garas J, Tsawdaroglou N, Sekeris CE. The detection of glucocorticoid receptors in breast cancer by immunocytochemical and biochemical methods. Int J Cancer 1982;29:147-152.
19. Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, et al. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer. Cancer Res 1979;39:1447-1454.
20. Liu SH, Otal-Brun M, Webb TE. Glucocorficoid receptors in human tumors. Cancer Lett 1980;10:269-275.
21. Smith RA, Lea RA, Curran JE, Weinstein SR, Griffiths LR. Expression of glucocorticoid and progesterone nuclear receptor genes in archival breast cancer tissue. Breast Cancer Res 2003;5:R9-R12.
22. Stjernholm-Vladic Y, Wang H, Stygar D, Ekman G, Sahlin L. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol 2004;18:41-46.
23. Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 1996;93:9821-9826.
24. Deugnier MA, Teuliere J, Faraldo MM, Thiery JP, Glukhova MA. The importance of being a myoepithelial cell. Breast Cancer Res 2002;4:224-230.
25. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, et al. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Cancer Res 2004;64:3037-3045.
26. Page MJ, Amess B, Townsend RR, Parekh R, Herath A, Brusten L, et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. Proc Natl Acad Sci U S A 1999;96:12589-12594.
27. Pujols L, Mullol J, Roca-Ferrer J, Torrego A, Xaubet A, Cidlowski JA, et al. Expression of glucocorticoid. receptor alpha- and beta-isoforms in human cells and tissues. Am J Physiol Cell Physiol 2002;283:C1324-C1331.
28. Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, et al. p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000;157:1769-1775.
29. Reis-Filho JS, Milanezi F, Paredes J, Silva P, Pereira EM, Maeda SA, et al. Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast. Appl Immunohistochem Mol Morphol 2003;11:1-8.
30. Lien HC, Lin CW, Mao TL, Kuo SH, Hsiao CH, Huang CS. p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components. J Pathol 2004;204:131-139.
31. Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu 1992;27(Pt 2):89-119.
32. Harb JM, Komorowski RA, Vitali CM. Metaplastic breast carcinoma invading chest wall. Ultrastruct Pathol 1995;19:439-443.
33. Sapino A, Papotti M, Sanfilippo B, Gugliotta P, Bussolati G. Tumor types derived from epithelia] and myoepithelial cell lines of R3230AC rat mammary carcinoma. Cancer Res 1992;52:1553-1560.
34. Zhuang Z, Lininger RA, Man YG, Albuquerque A, Merino MJ, Tavassoli FA. Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Mod Pathol 1997;10:354-362.
35. Koker MM, Kleer CG. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004;28:1506-1512.
36. Noguchi S, Motomura K, Inaji H, Imaoka S, Koyama H. Clonal analysis of fibroadenoma and phyllodes tumor of the breast. Cancer Res 1993;53:4071-4074.
37. Wu W, Chaudhuri S, Brickley DR, Pang D, Karrison T, Conzen SD. Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells. Cancer Res 2004;64:1757-1764.